Target intelligence / Profile preview

Transcription factor 7-like 1 (TCF7L1)

Target
TCF7L1
Molecular classification
Transcription factor
01

Overview

Transcription factor 7-like 1 (TCF7L1) is a member of the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) family of transcription factors and encodes a high-mobility group (HMG) box protein involved in mediating Wnt/β-catenin signaling[2][4]. TCF7L1 predominantly functions as a transcriptional repressor but can act as an activator in the presence of β-catenin, regulating key processes such as cellular differentiation (notably in adipogenesis, epidermal development, and pituitary formation), cell cycle progression, and cellular senescence[1][2][3][4]. Genetic studies have linked TCF7L1 to type 2 diabetes, cancer, developmental defects, and neurodevelopmental disorders, highlighting its diverse and critical regulatory functions. TCF7L1 modulates target gene expression by direct DNA binding and recruitment of chromatin-modifying enzymes, and acts as a molecular hub integrating cell signaling pathways relevant for development and disease[1][3][4].

Other names
TCF3TCF-3HMG box transcription factor 3transcription factor 7-like 1 (T-cell specific, HMG-box)
02

Mechanism of action

Modulation of Wnt signaling through transcriptional repression or activation (dependent on β-catenin interaction) Recruitment of chromatin-modifying enzymes (e.g., HDAC1) for gene silencing

03

Biological functions

Regulation of gene expressionWnt signaling pathway mediationTranscriptional repressionCellular differentiation (notably adipogenesis, epidermal differentiation, pituitary development)Regulation of cell cycle genesCellular senescence
04

Disease associations

CancerDevelopmental disorders (hypopituitarism, forebrain/pituitary defects, septo-optic dysplasia)Metabolic disorder (links to type 2 diabetes)Neurodevelopmental disorders (autism spectrum disorder)
05

Safety considerations

Potential developmental toxicity, as null mutations are embryonic lethal in mice[1]Possible tissue-specific adverse effects due to broad regulatory roles in differentiation and organogenesis[1][3]

Beyond the preview

Go deeper on Transcription factor 7-like 1 (TCF7L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor 7-like 1 (TCF7L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call